F. Hafezi, C. Grimm, A. Wenzel, M. Abegg, M. Yaniv, C. E. Remé: Retinal photoreceptors are apoptosis-competent in the absence of JunD/AP-1. In: Cell death and differentiation. Band 6, Nummer 10, Oktober 1999, S. 934–936, doi:10.1038/sj.cdd.4400574, PMID 10617374.
C. Grimm, A. Wenzel, F. Hafezi, S. Yu, T. M. Redmond, C. E. Remé: Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration. In: Nature genetics. Band 25, Nummer 1, Mai 2000, S. 63–66, doi:10.1038/75614, PMID 10802658.
C. Grimm, A. Wenzel, A. Behrens, F. Hafezi, E. F. Wagner, C. E. Remé: AP-1 mediated retinal photoreceptor apoptosis is independent of N-terminal phosphorylation of c-Jun. In: Cell death and differentiation. Band 8, Nummer 8, August 2001, S. 859–867, doi:10.1038/sj.cdd.4400871, PMID 11526439.
G. F. Sandvik, A. Thorsrud, M. Råen, A. E. Østern, M. Sæthre, L. Drolsum: Does Corneal Collagen Cross-linking Reduce the Need for Keratoplasties in Patients With Keratoconus? In: Cornea. Band 34, Nummer 9, September 2015, S. 991–995, doi:10.1097/ICO.0000000000000460, PMID 25970434.
L. M. Ittner, H. Wurdak, K. Schwerdtfeger, T. Kunz, F. Ille, P. Leveen, T. A. Hjalt, U. Suter, S. Karlsson, F. Hafezi, W. Born, L. Sommer: Compound developmental eye disorders following inactivation of TGFbeta signaling in neural-crest stem cells. In: Journal of biology. Band 4, Nummer 3, 2005, S. 11, doi:10.1186/jbiol29, PMID 16403239, PMC 1414066 (freier Volltext).
Patentanmeldung WO2014194435A3: Method of applying a composition and pharmaceutical composition with a regimen of administering it, including photo-activating the active component. Angemeldet am 4. Juni 2014, veröffentlicht am 5. Februar 2015, Erfinder: Farhad Hafezi, Oliver Richoz.
Patent EP2701645B1: Vorrichtung zur Behandlung und/oder Vorbeugung von Hornhauterkrankungen. Angemeldet am 23. April 2012, veröffentlicht am 21. November 2018, Erfinder: Farhad Hafezi, Oliver Richoz.
L. M. Böhlen, M. de Courten, F. Hafezi, S. Shaw, W. Riesen, P. Weidmann: Insulin sensitivity and atrial natriuretic factor during beta-receptor modulation with celiprolol in normal subjects. In: Journal of cardiovascular pharmacology. Band 23, Nummer 6, Juni 1994, S. 877–883, PMID 7523778.
F. Hafezi, J. P. Steinbach, A. Marti, K. Munz, Z. Q. Wang, E. F. Wagner, A. Aguzzi, C. E. Remé: The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo. In: Nature medicine. Band 3, Nummer 3, März 1997, S. 346–349, PMID 9055866.
A. Marti, F. Hafezi, N. Lansel, M. E. Hegi, A. Wenzel, C. Grimm, G. Niemeyer, C. E. Remé: Light-induced cell death of retinal photoreceptors in the absence of p53. In: Investigative ophthalmology & visual science. Band 39, Nummer 5, April 1998, S. 846–849, PMID 9538895.
F. Hafezi, C. Grimm, A. Wenzel, M. Abegg, M. Yaniv, C. E. Remé: Retinal photoreceptors are apoptosis-competent in the absence of JunD/AP-1. In: Cell death and differentiation. Band 6, Nummer 10, Oktober 1999, S. 934–936, doi:10.1038/sj.cdd.4400574, PMID 10617374.
A. Fleischmann, F. Hafezi, C. Elliott, C. E. Remé, U. Rüther, E. F. Wagner: Fra-1 replaces c-Fos-dependent functions in mice. In: Genes & development. Band 14, Nummer 21, November 2000, S. 2695–2700, PMID 11069886, PMC 317035 (freier Volltext).
C. Grimm, A. Wenzel, F. Hafezi, S. Yu, T. M. Redmond, C. E. Remé: Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration. In: Nature genetics. Band 25, Nummer 1, Mai 2000, S. 63–66, doi:10.1038/75614, PMID 10802658.
C. Grimm, A. Wenzel, A. Behrens, F. Hafezi, E. F. Wagner, C. E. Remé: AP-1 mediated retinal photoreceptor apoptosis is independent of N-terminal phosphorylation of c-Jun. In: Cell death and differentiation. Band 8, Nummer 8, August 2001, S. 859–867, doi:10.1038/sj.cdd.4400871, PMID 11526439.
A. Wenzel, C. E. Reme, T. P. Williams, F. Hafezi, C. Grimm: The Rpe65 Leu450Met variation increases retinal resistance against light-induced degeneration by slowing rhodopsin regeneration. In: The Journal of neuroscience : the official journal of the Society for Neuroscience. Band 21, Nummer 1, Januar 2001, S. 53–58, PMID 11150319.
Mackool RJ: Crosslinking for iatrogenic keratectasia after LASIK and for keratoconus.IN: Journal Cataract Refract Surg. Band 34, Nummer 6, Juni 2008, S. 879; PMID 18498974.
L. M. Böhlen, M. de Courten, F. Hafezi, S. Shaw, W. Riesen, P. Weidmann: Insulin sensitivity and atrial natriuretic factor during beta-receptor modulation with celiprolol in normal subjects. In: Journal of cardiovascular pharmacology. Band 23, Nummer 6, Juni 1994, S. 877–883, PMID 7523778.
G. F. Sandvik, A. Thorsrud, M. Råen, A. E. Østern, M. Sæthre, L. Drolsum: Does Corneal Collagen Cross-linking Reduce the Need for Keratoplasties in Patients With Keratoconus? In: Cornea. Band 34, Nummer 9, September 2015, S. 991–995, doi:10.1097/ICO.0000000000000460, PMID 25970434.
L. M. Ittner, H. Wurdak, K. Schwerdtfeger, T. Kunz, F. Ille, P. Leveen, T. A. Hjalt, U. Suter, S. Karlsson, F. Hafezi, W. Born, L. Sommer: Compound developmental eye disorders following inactivation of TGFbeta signaling in neural-crest stem cells. In: Journal of biology. Band 4, Nummer 3, 2005, S. 11, doi:10.1186/jbiol29, PMID 16403239, PMC 1414066 (freier Volltext).
Search results – Items: 1 to 20 of 149. In: PubMed. US National Library of Medicine National Institutes of Health, abgerufen am 24. April 2019 (englisch, Listenerstellung nach Datenbanksuche nach Farhad Hafezi).